Discover how automated assays are helping drive targeted protein degradation (TPD) research programs and Degrader development. During this webinar, the Bio-Techne® team will be joined by Dr Gary Allenby, CSO at Aurelia Bioscience, who will delve deeper into how their research team is utilizing automated Western blot systems from ProteinSimple™, a Bio-Techne brand.
Find out how high-throughput Western blotting platforms Wes™ and Jess™ from ProteinSimple can be used to rapidly and reproducibly quantify protein knockdown following treatment with Degraders.


Gary Allenby

Dr. Gary Allenby
Aurelia Bioscience

Hannah Maple

Dr. Hannah Maple
Innovation Manager
Tocris, a Bio-Techne brand

Carsten Lueck

Dr. Carsten Lück
FAS and Science Manager, EMEA
ProteinSimple, a Bio-Techne brand